South Korean medical AI company Lunit has recently secured deals with hospitals in Europe, where the medical device market – the second largest after the North American market – is worth $155 billion.
It won the contract to supply a lung disease screening solution to TeleDiag, the largest teleradiology group in France.
Lunit was also chosen to provide a mammography analysis solution to the...
Samsung to integrate Lunit's AI in premium X-ray devices
South Korean medical AI provider Lunit has signed a three-year supply contract with Samsung Electronics.
The deal is for the integration of Lunit's two chest X-ray AI solutions – Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage – into Samsung's line of premium X-ray devices.
According to a press release, the AI-integrated X-ray devices will...
Shareholders of KOSDAQ-listed Lunit have recently participated in the company's recent capital raise, paying-in $150 million to fund its development of "next-generation" products and further expansion in the West.
Meanwhile, the AI cancer diagnostics solutions provider obtained its third 510(k) clearance from the United States Food and Drug Administration.
WHAT IT'S FOR
In a company disclosure,...
Nesa obtains US FDA 510(k) for fibroid mapping tech
Indian femtech Nesa Medtech has received the United States Food and Drug Administration 510(k) clearance for its fibroid mapping tool.
Its Fibroid Mapping Reviewer Application assists in the diagnosis and planning of interventional procedures for patients with uterine fibroids. It generates a 3D model of the uterus from ultrasound images where...
Saudi Arabia's Seha Virtual Hospital, touted as the largest virtual hospital in the world, has chosen South Korean medical AI company Lunit to deliver AI solutions to support the kingdom's national cancer and tuberculosis screening programme.
Launched in 2022, Seha Virtual Hospital is a key piece of healthcare innovation under "Saudi Vision 2030." The hospital is providing medical services to...
Medical IP gets US FDA nod for AI body composition analysis software
South Korean medical imaging company Medical IP has obtained a United States Food and Drug Administration 510(k) clearance for its AI-powered body composition analysis software.
According to the company, DeepCatch is the first FDA-approved AI software that automatically analyses body components, such as skin, bone, muscle,...
South Korean medical AI company Lunit is helping raise Sweden's cancer screening capability by partnering with one of the country's biggest private healthcare providers.
It recently signed a three-year agreement with Capio S:t Göran Hospital to supply and license its AI-powered mammography analysis software Lunit INSIGHT MMG.
According to a press release, the AI tool will enable the hospital to...
Lunit is expanding its deployment of an AI imaging solution to South Korean military facilities and troops overseas.
This comes following the successful pilot deployment of Lunit INSIGHT CXR, its AI-powered chest x-ray analysis software, last year in the army, navy, and air force medical institutions, including the Armed Forces Medical Command and the Armed Forces Capital Hospital.
The company...
Tricog snaps up $9M funding for US expansion
AI-based cardiac diagnosis solution provider Tricog has raised Rs 700 million ($8.5 million) in a Series B2 funding round led by Japanese institutions, Omron and Sony Innovation Fund. The round was also participated by the University of Tokyo Edge Capital, Inventus Partners, and Singapore's SG Innovate.
The startup plans to use its fresh funds for its...
Lunit obtains new CE mark for AI DBT solution
South Korean medical AI company Lunit has received a CE mark under Europe's latest Medical Device Regulation for its AI software for digital breast tomosynthesis (DBT) analysis.
Called Lunit INSIGHT DBT, the software solution analyses 3D images from DBT, enabling fast and accurate diagnosis of breast cancer.
In a press statement, Lunit disclosed its...
